MD3229F1 - Method of mammary cancer preoperative treatment - Google Patents

Method of mammary cancer preoperative treatment Download PDF

Info

Publication number
MD3229F1
MD3229F1 MDA20060176A MD20060176A MD3229F1 MD 3229 F1 MD3229 F1 MD 3229F1 MD A20060176 A MDA20060176 A MD A20060176A MD 20060176 A MD20060176 A MD 20060176A MD 3229 F1 MD3229 F1 MD 3229F1
Authority
MD
Moldova
Prior art keywords
mammary cancer
preoperative treatment
cancer preoperative
session
days
Prior art date
Application number
MDA20060176A
Other languages
Romanian (ro)
Other versions
MD3229G2 (en
Inventor
Vasile Jovmir
Anastasia Stanislav
Lilia MORARU
Original Assignee
Vasile Jovmir
Anastasia Stanislav
Lilia MORARU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vasile Jovmir, Anastasia Stanislav, Lilia MORARU filed Critical Vasile Jovmir
Priority to MDA20060176A priority Critical patent/MD3229G2/en
Publication of MD3229F1 publication Critical patent/MD3229F1/en
Publication of MD3229G2 publication Critical patent/MD3229G2/en

Links

Landscapes

  • Radiation-Therapy Devices (AREA)

Abstract

Inventia se refera la medicina, in special la oncologie si chirurgia glandei mamare. Esenta inventiei consta in aceea ca se efectueaza radioterapia pe doua campuri, si anume un camp include ganglionii limfatici supra-, subclaviculari si axilari, iaral doilea - glanda mamara propriu-zisa, cu o dozade 3 Gy la o sedinta pe fiecare camp, care se efectueaza timp de 10 zile, cu o intrerupere de 2 zile dupa a 5-a sedinta, doza sumara fiind de 30 Gy.The invention relates to medicine, in particular to oncology and surgery of the mammary gland. The essence of the invention consists in the fact that radiotherapy is performed on two fields, namely one field includes the upper-, subclavicular and axillary lymph nodes, and the second - the mammary gland itself, with a dose of 3 Gy at a session in each field, which is performs for 10 days, with an interruption of 2 days after the 5th session, the summary dose being 30 Gy.

MDA20060176A 2006-06-30 2006-06-30 Method of mammary cancer preoperative treatment MD3229G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20060176A MD3229G2 (en) 2006-06-30 2006-06-30 Method of mammary cancer preoperative treatment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20060176A MD3229G2 (en) 2006-06-30 2006-06-30 Method of mammary cancer preoperative treatment

Publications (2)

Publication Number Publication Date
MD3229F1 true MD3229F1 (en) 2007-01-31
MD3229G2 MD3229G2 (en) 2007-07-31

Family

ID=37776654

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20060176A MD3229G2 (en) 2006-06-30 2006-06-30 Method of mammary cancer preoperative treatment

Country Status (1)

Country Link
MD (1) MD3229G2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD3772G2 (en) * 2008-05-12 2009-07-31 Общественное Медико-Санитарное Учреждение Онкологический Институт Method for treating mammary cancer with metastases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD446G2 (en) * 1995-07-07 1996-11-30 Онкологический Институт Республики Молдова Method for mamma cancer treatment
MD798G2 (en) * 1996-11-15 1998-05-31 Онкологический Институт Республики Молдова Method of the mamma cancer treatment
MD1569G2 (en) * 1999-12-17 2001-06-30 Онкологический Институт Республики Молдова Method of treatment of breast canceeeer in the preoperation period
MD2106C2 (en) * 2000-10-13 2004-01-31 Технический университет Молдовы Wind helical turbine

Also Published As

Publication number Publication date
MD3229G2 (en) 2007-07-31

Similar Documents

Publication Publication Date Title
CY1125213T1 (en) BREAST CANCER TREATMENT METHODS AR+
SI3883579T1 (en) Combination therapy that includes a KRAS-G12C inhibitor and one or more additional pharmaceutically active agents for the treatment of cancer
CL2020002737A1 (en) Methods for expanding tumor infiltrating lymphocytes (divisional application no. 201902769)
NZ784224A (en) Parp1 inhibitors
PH12019501575A1 (en) ISOFORM-SPECIFIC, CONTEXT-PERMISSIVE TGFá1 INHIBITORS AND USE THEREOF
DOP2017000271A (en) PATIENT CONDITIONING METHODS FOR T-LYMPHOCYT TREATMENT
EA201892510A2 (en) COMBINED THERAPY FOR CANCER TREATMENT
EA201792191A1 (en) FGFR / PD-1 COMBINED THERAPY FOR THE TREATMENT OF MALIGNANT TUMOR
MX2022008868A (en) Treatment of cancer with tg02.
MX2018001802A (en) Methods for treating metastatic pancreatic cancer using combination therapies comprising liposomal irinotecan and oxaliplatin.
CY1111565T1 (en) ZD6474 5-FU AND / OR CPT-11 COMBINATION TREATMENT
MA38318A1 (en) Compositions of inorganic nanoparticles combined with ionizing radiation for the treatment of cancer
MX2023000549A (en) Combinations for the treatment of neoplasms using quiescent cell targeting and egfr inhibitors.
JOP20220104A1 (en) Dosing regimen for anti-dll3 agents
CY1125307T1 (en) METHOD OF TREATMENT OF PATIENTS WITH RIVAROXAMPAN AND VERAPAMIL ADMINISTRATION
PH12020550462A1 (en) Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same
CY1117438T1 (en) METHOD FOR PREVENTION AND THERAPEUTIC TREATMENT
AR071309A1 (en) METHODS TO TREAT CANCER AND EQUIPMENT WITH A COMBINATION THAT INCLUDES A HUMANIZED L2G7 ANTIBODY AND A PTEN AGONIST
CY1123696T1 (en) DRUG FOR THE TREATMENT OF DIABETIC FOOT INFECTIONS
JOP20200124A1 (en) Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
MX2022003190A (en) Combinational therapies for treatment of cancer comprising a bacteriochlorophyll derivative.
MD3248F1 (en) Method of mammary cancer treatment
MX2021011289A (en) Compositions comprising pkm2 modulators and methods of treatment using the same.
JO3737B1 (en) Therapeutic combinations of orally administered paclitaxel and a P-gp inhibitor for the treatment of cancer
MX2021004463A (en) Arginine depletion therapy for treatment of gamt deficiency.

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees